Fig. 3From: Rapidly progressive glomerulonephritis secondary to anti-GBM disease associated with MPO-ANCA: a case reportGraph showing patient’s evolution during the 7 months of treatment and follow-up, taking into account serum creatinine, hemoglobin, anti-GBM, anti-Mpo, and anti-Pr-3Back to article page